Examining the relationship between depression and asthma exacerbations in a prospective follow-up study

Psychosomatic Medicine

Volumn 75, Issue 3, 2013, Pages 305-310

  Ahmedani, Brian K ^a   Peterson, Edward L ^a   Wells, Karen E ^a   Williams, L Keoki ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

asthma; depression; emergency care; mental health services; oral steroid

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOSTEROID; STEROID;

ADULT; ARTICLE; ASTHMA; BINOMIAL DISTRIBUTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; EMERGENCY WARD; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; DEPRESSIVE DISORDER; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; YOUNG ADULT;

EID: 84876294094     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3182864ee3     Document Type: Article

References (59)

1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-27.
2. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:593-602.
3. Centers for Disease Control and Prevention (CDC). Self-reported asthma prevalence and control among adultsVUnited States, 2001. MMWR Morb Mortal Wkly Rep 2003;52:381-4.
4. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851-8.
5. Katon W, Lyles CR, Parker MM, Karter AJ, Huang ES, Whitmer RA. Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study. Arch Gen Psychiatry 2011; 69:410-7.
6. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl 1996;168:17-30.
7. Demyttenaere K, Bruffaerts R, Lee S, Posada-Villa J, Kovess V, Angermeyer MC, Levinson D, de GG, Nakane H, Mneimneh Z, Lara C, de GR, Scott KM, Gureje O, Stein DJ, Haro JM, Bromet EJ, Kessler RC, Alonso J, Von KM. Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys. Pain 2007;129: 332-42.
8. Opolski M, Wilson I. Asthma and depression: a pragmatic review of the literature and recommendations for future research. Clin Pract Epidemiol Ment Health 2005;1:18.
9. Katon W, Lozano P, Russo J, McCauley E, Richardson L, Bush T. The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls. J Adolesc Health 2007;41:455-63.
10. Vila G, Nollet-Clemencon C, de BJ, Mouren-Simeoni MC, Scheinmann P. Prevalence of DSM IV anxiety and affective disorders in a pediatric popu-lationof asthmatic children and adolescents. JAffect Disord 2000;58:223-31.
11. Goodwin RD, Jacobi F, Thefeld W. Mental disorders and asthma in the community. Arch Gen Psychiatry 2003;60:1125-30.
12. Scott KM, Von Korff M, Angermeyer MC, Benjet C, Bruffaerts R, de Girolamo G, Haro JM, Lepine JP, Ormel J, Posada-Villa J, Tachimori H, Kessler RC. Association of childhood adversities and early-onset mental disorders with adult-onset chronic physical conditions. Arch Gen Psychiatry 2011;68:838-44.
13. Katon W. Asthma, suicide risk, and psychiatric comorbidity. Am J Psychiatry 2010;167:1020-2.
14. Walters P, Schofield P, Howard L, Ashworth M, Tylee A. The relationship between asthma and depression in primary care patients: a historical cohort and nested case control study. PLoS One 2011;6:e20750.
15. Wang G, Zhou T, Wang L, Wang L, Fu JJ, Zhang HP, Ji YL. Relationship between current psychological symptoms and future risk of asthma outcomes: a 12-month prospective cohort study. J Asthma 2011;48:1041-50.
16. Kullowatz A, Kanniess F, Dahme B, Magnussen H, Ritz T. Association of depression and anxiety with health care use and quality of life in asthma patients. Respir Med 2007;101:638-44.
17. Dahlen I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 2002;122:1633-7.
18. Schneider A, Lowe B, Meyer FJ, Biessecker K, Joos S, Szecsenyi J. Depression and panic disorder as predictors of health outcomes for patients with asthma in primary care. Respir Med 2008;102:359-66.
19. Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, Ownby DR, Johnson CC. Relationship between adherence to inhaled corticoste-roids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004;114:1288-93.
20. Williams LK, Joseph CL, Peterson EL, Wells K, Wang M, Chowdhry VK, Walsh M, Campbell J, Rand CS, Apter AJ, Lanfear DE, Tunceli K, Pladevall M. Patients with asthma who do not fill their inhaled cortico-steroids: a study of primary nonadherence. J Allergy Clin Immunol 2007; 120:1153-9.
21. Simon GE, Ludman EJ. Predictors of early dropout from psychotherapy for depression in community practice. Psychiatr Serv 2010;61:684-9.
22. Akincigil A, Bowblis JR, Levin C, Walkup JT, Jan S, Crystal S. Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Med Care 2007;45:363-9.
23. Williams LK, Peterson EL, Wells K, Ahmedani BK, Kumar R, Burchard EG, Chowdhry VK, Favro D, Lanfear DE, Pladevall M. Quantifying the proportion of severe asthma exacerbations attributable to inhaled cortico-steroid nonadherence. J Allergy Clin Immunol 2011;128:1185-91.
24. Williams LK, Peterson EL, Wells K, Campbell J, Wang M, Chowdhry VK, Walsh M, Enberg R, Lanfear DE, Pladevall M. A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. J Allergy Clin Immunol 2010;126:225-31.
25. Wells K, Pladevall M, Peterson EL, Campbell J, Wang M, Lanfear DE, Williams LK. Race-ethnic differences in factors associated with inhaled steroid adherence among adults with asthma. Am J Respir Crit Care Med 2008;178:1194-201.
26. Weinman J, Petrie KJ, Moss-Morris R, Horne R. The Illness Perception Questionnaire: a new method for assessing the cognitive representation of illness. Psychol Health 1996;11:431-45.
27. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999;14:1-24.
28. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113:59-65.
29. Parkerson GR Jr, Broadhead WE, Tse CK. Validation of the Duke Social Support and Stress Scale. Fam Med 1991;23:357-60.
30. Krieger N, Smith K, Naishadham D, Hartman C, Barbeau EM. Experiences of discrimination: validity and reliability of a self-report measure for population health research on racism and health. Soc Sci Med 2005;61: 1576-96.
31. Wright RJ, Mitchell H, Visness CM, Cohen S, Stout J, Evans R, Gold DR. Community violence and asthma morbidity: the Inner-City Asthma Study. Am J Public Health 2004;94:625-32.
32. Wallston KA, Wallston BS, DeVellis R. Development of the Multidimensional Health Locus of Control (MHLC) scales. Health Educ Monogr 1978;6:160-70.
33. Wallston KA, Malcarne VL, Flores L, Hansdottir I, Smith CA, Stein MJ, Weisman MH, Clements PJ. Does God determine your health? The God Locus of Health Control Scale. Cognitive Ther Res 1999;23:131-42.
34. Chaplin WF, Davidson K, Sparrow V, Stuhr J, van Roosenmale E, Wallston KA. A structural evaluation of the expanded Multidimensional Health Locus of Control Scale with a diverse sample of Caucasian/European, native, and black Canadian women. J Health Psychol 2001;6:447-55.
35. Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997;12:439-45.
36. Whooley MA, Simon GE. Managing depression in medical outpatients. N Engl J Med 2000;343:1942-50.
37. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
38. Yang JJ, Burchard EG, Choudhry S, Johnson CC, Ownby DR, Favro D, Chen J, Akana M, Ha C, Kwok PY, Krajenta R, Havstad SL, Joseph CL, Seibold MA, Shriver MD, Williams LK. Differences in allergic sensitiza-tion by self-reported race and genetic ancestry. J Allergy Clin Immunol 2008;122:820-7.
39. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O'Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180:59-99.
40. Fuhlbrigge A, Peden D, Apter AJ, Boushey HA, Camargo CA, Gern J, Heymann PW, Martinez FD, Mauger D, Teague WG, Blaisdell C. Asthma Outcomes: Exacerbations. J Allergy Clin Immunol 2012;129:S34-48.
41. Alonzo DM, Harkavy-Friedman JM, Stanley B, Burke A, Mann JJ, Oquendo MA. Predictors of treatment utilization in major depression. Arch Suicide Res 2011;15:160-71.
42. SAS Institute Inc. SAS/STAT Users Guide. Version 9. 2nd ed. Cary, NC: SAS Institute Inc.; 2008.
43. Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health 2005;95(Suppl 1):S144-50.
44. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
45. Richardson LP, Lozano P, Russo J, McCauley E, Bush T, Katon W. Asthma symptom burden: relationship to asthma severity and anxiety and depression symptoms. Pediatrics 2006;118:1042-51.
46. Richardson LP, Russo JE, Lozano P, McCauley E, Katon W. The effect of comorbid anxiety and depressive disorders on health care utilization and costs among adolescents with asthma. Gen Hosp Psychiatry 2008;30: 398-406.
47. Wang PS, Berglund P, Olfson M, Pincus HA, Wells KB, Kessler RC. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:603-13.
48. Mojtabai R, Olfson M. Treatment seeking for depression in Canada and the United States. Psychiatr Serv 2006;57:631-9.
49. Katon W, Unutzer J, Russo J. Major depression: the importance of clinical characteristics and treatment response to prognosis. Depress Anxiety 2010; 27:19-26.
50. Currie GP, Douglas JG, Heaney LG. Difficult to treat asthma in adults. BMJ 2009;338:b494.
51. Van Lieshout RJ, Bienenstock J, MacQueen GM. A review of candidate pathways underlying the association between asthma and major depressive disorder. Psychosom Med 2009;71:187-95.
52. Goodwin RD, Fergusson DM, Horwood LJ. Asthma and depressive and anxiety disorders among young persons in the community. Psychol Med 2004;34:1465-74.
53. Brown ES, Vera E, Frol AB, Woolston DJ, Johnson B. Effects of chronic prednisone therapy on mood and memory. J Affect Disord 2007;99: 279-83.
54. Brown ES, Gan V, Jeffress J, Mullen-Gingrich K, Khan DA, Wood BL, Miller BD, Gruchalla R, Rush AJ. Psychiatric symptomatology and disorders in caregivers of children with asthma. Pediatrics 2006;118:e1715-20.
55. Fonken LK, Xu X, Weil ZM, Chen G, Sun Q, Rajagopalan S, Nelson RJ. Air pollution impairs cognition, provokes depressive-like behaviors and alters hippocampal cytokine expression and morphology. Mol Psychiatry 2011;16:987-95, 973.
56. Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 2009;50: 613-21.
57. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003;41:1284-92.
58. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
59. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004;27:2800-5.